Patents by Inventor Shelly Glase

Shelly Glase has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted morpholine compounds for the treatment of central nervous system disorders
    Publication number: 20050245519
    Abstract: This invention relates to compounds of the formulae I wherein R1-R8, A, X, and Z are defined as in the specification, pharmaceutical compositions containing them and their use in the treatment of central nervous system disorders.
    Type: Application
    Filed: April 29, 2005
    Publication date: November 3, 2005
    Inventors: Nancy Barta, Shelly Glase, David Gray, Gregory Reichard, Lloyd Simons, Weijan Xu
  • Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders
    Publication number: 20050096327
    Abstract: This invention relates to compounds of the formula 1 wherein R1, R2, and R3 and R4 are defined as in the specification, pharmaceutical compositions containing them and their use in the treatment of central nervous system disorders.
    Type: Application
    Filed: November 2, 2004
    Publication date: May 5, 2005
    Inventors: Bradley Caprathe, Shelly Glase, Zissis Konstantinou, Robert Schelkun, Susan Sheehan, Anthony Thomas, Po-Wai Yuen
  • Substituted piperazines and piperidines as central nervous system agents
    Patent number: 6121267
    Abstract: Di- and tri-Methoxybenzyl substituted piperazines and piperidines and derivatives thereof are described, as well as methods for the preparation and pharmaceutical composition of same, which are useful as central nervous system agents and are particularly useful as dopamine antagonists and antipsychotic agents.
    Type: Grant
    Filed: August 5, 1999
    Date of Patent: September 19, 2000
    Assignee: Warner-Lambert Company
    Inventors: Shelly A. Glase, Terri S. Purchase, Lawrence D. Wise
  • Substituted piperazines and piperidines as central nervous system agents
    Patent number: 5965560
    Abstract: Substituted piperazines and piperidines and derivatives thereof are described, as well as methods for the preparation and pharmaceutical composition of same, which are useful as central nervous system agents and are particularly useful as dopamine antagonists and antipsychotic agents.
    Type: Grant
    Filed: December 19, 1997
    Date of Patent: October 12, 1999
    Assignee: Warner-Lambert Company
    Inventors: Shelly A. Glase, Terri S. Purchase, Lawrence D. Wise
  • Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents
    Patent number: 5620988
    Abstract: Substituted tetrahydropyridines and hydroxypiperidines and derivatives thereof are described, as well as methods for the preparation and pharmaceutical composition of the same, which are useful as central nervous system agents and are particularly useful as dopaminergic, antipsychotic, and antihypertensive agents as well as for treating hyperprolactinaemia-related conditions and central nervous system disorders.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: April 15, 1997
    Assignee: Warner-Lambert Company
    Inventors: Shelly Glase, Juan C. Jaen, Sarah J. Smith, Lawrence D. Wise
  • Benzimidazoles and imidazopyridines as central nervous system agents
    Patent number: 5486517
    Abstract: Benzimidazoles and imidazopyridines are described, as well as methods for the preparation and pharmaceutical composition of same, which are useful as central nervous system agents and are particularly useful as antipsychotic agents and for the treatment of disorders which respond to dopaminergic blockade including psychotis depression, substance abuse, and compulsive disorders.
    Type: Grant
    Filed: May 10, 1994
    Date of Patent: January 23, 1996
    Assignee: Warner-Lambert Company
    Inventors: Dennis M. Downing, Shelly A. Glase, Stephen J. Johnson, Lawrence D. Wise, Jonathan L. Wright
  • Substituted tetrahydrophyridines and hydroxypiperidines as central nervous system agents
    Patent number: 5466698
    Abstract: Substituted tetrahydropyridines and hydroxypiperidines and derivatives thereof are described, as well as methods for the preparation and pharmaceutical composition of the same, which are useful as central nervous system agents and are particularly useful as dopaminergic, antipsychotic, and antihypertensive agents as well as for treating hyperprolactinaemia-related conditions and central nervous system disorders.
    Type: Grant
    Filed: September 29, 1993
    Date of Patent: November 14, 1995
    Assignee: Warner-Lambert Company
    Inventors: Shelly Glase, Juan C. Jaen, Sarah J. Smith, Lawrence D. Wise
  • Naphthalamides as central nervous system agents
    Patent number: 5395835
    Abstract: Naphthalamides are described, as well as methods for the preparation and pharmaceutical composition of same, which are useful as central nervous system agents and are particularly useful as antipsychotic agents and as agents for the treatment of disorders which respond to dopaminergic blockade including psychotic depression, substance abuse, and compulsive disorders.
    Type: Grant
    Filed: March 24, 1994
    Date of Patent: March 7, 1995
    Assignee: Warner-Lambert Company
    Inventors: Shelly A. Glase, Suzanne R. Kesten, Lawrence D. Wise, Jonathan Wright
  • Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents
    Patent number: 5273977
    Abstract: Substituted tetrahydropyridines and hydroxypiperidines and derivatives thereof are described, as well as methods for the preparation and pharmaceutical composition of the same, which are useful as central nervous system agents and are particularly useful as dopaminergic, antipsychotic, and antihypertensive agents as well as for treating hyperprolactinaemia-related conditions and central nervous system disorders.
    Type: Grant
    Filed: October 24, 1991
    Date of Patent: December 28, 1993
    Assignee: Warner-Lambert Company
    Inventors: Shelly Glase, Juan C. Jaen, Sarah J. Smith, Lawrence D. Wise
  • Substituted piperazines as central nervous system agents
    Patent number: 5270312
    Abstract: Substituted piperazines and derivatives of Formula I ##STR1## are described, as well as methods for the preparation and pharmaceutical composition of the same, which are useful as central nervous system agents and are particularly useful as dopaminergic, antipsychotic, and antihypertensive agents as well as for treating hyperprolactinaemia-related conditions and central nervous system disorders.
    Type: Grant
    Filed: October 24, 1991
    Date of Patent: December 14, 1993
    Assignee: Warner-Lambert Company
    Inventors: Shelly Glase, Juan C. Jaen, Sarah J. Smith, Lawrence D. Wise